Financials
- Market Capitalization 472.38 M
- Employee 129
- Founded 2018
- CEO N/A
- Website www.kyvernatx.com
- Headquarter Delaware, United States
- FIGI BBG00RCYMHR1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.58
売上高対価格比率
-6 934.07
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2938 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.61 USD | -8.52% | -21.08% | -3.01% | -22.60% | 486.32 M USD | ||
| 2951 | OCGN Ocugen, Inc. - Common Stock | 1.41 USD | -4.08% | -6.62% | +11.02% | +25.89% | 477.32 M USD | ||
| 2961 | VSTM Verastem, Inc. - Common Stock | 5.37 USD | -2.89% | +19.60% | +29.09% | +7.83% | 471.88 M USD | ||
| 2974 | PRTA Prothena Corporation plc - Ordinary Shares | 8.83 USD | -4.44% | -8.21% | +0.68% | +37.11% | 462.28 M USD |